The Influence of Fasting and Energy Restricting Diets on IGF-1 Levels in Humans: A Systematic Review and Meta-Analysis

Jamal Rahmani, Hamed Kord Varkaneh, Cain Clark, Hamid Zand, Hiba Bawadi, Paul Ryan, Somaye Fatahi, Y. Zhang

Research output: Contribution to journalArticle

Abstract

Background
Fasting and energy restricting diets have a potential means of delaying or preventing the onset of a range of age-related metabolic and neoplastic diseases. Consistently at the centre of this effect appears to be a significant reduction in circulating IGF-1 levels. The aim of the current systematic review and meta-analysis was to determine the influence of fasting and energy restriction on IGF-1 levels in human subjects.
Methods
A comprehensive systematic search was conducted from onset of the database to February 2019 in Embase, MEDLINE/PubMed, and SCOPUS to identify randomized clinical trials that investigating the impact of fasting or energy restriction circulating IGF-1 levels. Effect size was reported as weighted mean difference (WMD) and 95% confidence intervals (CI) using a random-effects models. Subgroup analysis was performed to identify the probable source of heterogeneity among trials.
Results
Total pooling of fasting and energy restriction randomised controlled trials in WMD analysis revealed no significant effect on circulating IGF-1 levels (WMD: -16.41 ng/ml, 95% CI: -35.88, 3.07). Sub grouped analysis fasting regimens appeared to substantially reduce IGF-1 (WMD: -28.87 ng/ml, 95% CI: -43.69, -14.05, I2=00%), energy restricting regimens failed to do the same (WMD: -10.98 ng/ml, 95% CI: -33.08, 11.11, I2=90%). Within this final subgrouping, it was observed that only energy restriction regimens of 50% or greater of normal daily energy intake were capable of significantly reducing IGF-1 levels (WMD: -36.57 ng/ml, 95% CI: -59.19, -13.95, I2=00%). Finally, a meta regression were noted in which the percentage restriction of daily energy intake inversely correlated with plasma IGF-1 levels (p=0.04).
Conclusion
This study uncovered that fasting significantly reduced levels of IGF-1, while energy restriction diets were successful only when intake was reduced by 50% or more.

Original languageEnglish
Article number100910
JournalAgeing Research Reviews
Volume53
Early online date19 May 2019
DOIs
Publication statusPublished - Aug 2019

Fingerprint

Nutrition
Insulin-Like Growth Factor I
Meta-Analysis
Fasting
Diet
Confidence Intervals
Energy Intake
Randomized Controlled Trials
Metabolic Diseases
PubMed
MEDLINE
Databases
Plasmas

Keywords

  • Energy restriction
  • Fasting
  • IGF-1

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Ageing
  • Molecular Biology
  • Neurology

Cite this

The Influence of Fasting and Energy Restricting Diets on IGF-1 Levels in Humans: A Systematic Review and Meta-Analysis. / Rahmani, Jamal; Varkaneh, Hamed Kord ; Clark, Cain; Zand, Hamid; Bawadi, Hiba; Ryan, Paul; Fatahi, Somaye; Zhang, Y.

In: Ageing Research Reviews, Vol. 53, 100910, 08.2019.

Research output: Contribution to journalArticle

Rahmani, Jamal ; Varkaneh, Hamed Kord ; Clark, Cain ; Zand, Hamid ; Bawadi, Hiba ; Ryan, Paul ; Fatahi, Somaye ; Zhang, Y. / The Influence of Fasting and Energy Restricting Diets on IGF-1 Levels in Humans: A Systematic Review and Meta-Analysis. In: Ageing Research Reviews. 2019 ; Vol. 53.
@article{1acb0b51dc9245e39bbdb80157a0fd52,
title = "The Influence of Fasting and Energy Restricting Diets on IGF-1 Levels in Humans: A Systematic Review and Meta-Analysis",
abstract = "BackgroundFasting and energy restricting diets have a potential means of delaying or preventing the onset of a range of age-related metabolic and neoplastic diseases. Consistently at the centre of this effect appears to be a significant reduction in circulating IGF-1 levels. The aim of the current systematic review and meta-analysis was to determine the influence of fasting and energy restriction on IGF-1 levels in human subjects.MethodsA comprehensive systematic search was conducted from onset of the database to February 2019 in Embase, MEDLINE/PubMed, and SCOPUS to identify randomized clinical trials that investigating the impact of fasting or energy restriction circulating IGF-1 levels. Effect size was reported as weighted mean difference (WMD) and 95{\%} confidence intervals (CI) using a random-effects models. Subgroup analysis was performed to identify the probable source of heterogeneity among trials.ResultsTotal pooling of fasting and energy restriction randomised controlled trials in WMD analysis revealed no significant effect on circulating IGF-1 levels (WMD: -16.41 ng/ml, 95{\%} CI: -35.88, 3.07). Sub grouped analysis fasting regimens appeared to substantially reduce IGF-1 (WMD: -28.87 ng/ml, 95{\%} CI: -43.69, -14.05, I2=00{\%}), energy restricting regimens failed to do the same (WMD: -10.98 ng/ml, 95{\%} CI: -33.08, 11.11, I2=90{\%}). Within this final subgrouping, it was observed that only energy restriction regimens of 50{\%} or greater of normal daily energy intake were capable of significantly reducing IGF-1 levels (WMD: -36.57 ng/ml, 95{\%} CI: -59.19, -13.95, I2=00{\%}). Finally, a meta regression were noted in which the percentage restriction of daily energy intake inversely correlated with plasma IGF-1 levels (p=0.04). ConclusionThis study uncovered that fasting significantly reduced levels of IGF-1, while energy restriction diets were successful only when intake was reduced by 50{\%} or more.",
keywords = "Energy restriction, Fasting, IGF-1",
author = "Jamal Rahmani and Varkaneh, {Hamed Kord} and Cain Clark and Hamid Zand and Hiba Bawadi and Paul Ryan and Somaye Fatahi and Y. Zhang",
year = "2019",
month = "8",
doi = "10.1016/j.arr.2019.100910",
language = "English",
volume = "53",
journal = "Ageing Research Reviews",
issn = "1568-1637",
publisher = "Elsevier",

}

TY - JOUR

T1 - The Influence of Fasting and Energy Restricting Diets on IGF-1 Levels in Humans: A Systematic Review and Meta-Analysis

AU - Rahmani, Jamal

AU - Varkaneh, Hamed Kord

AU - Clark, Cain

AU - Zand, Hamid

AU - Bawadi, Hiba

AU - Ryan, Paul

AU - Fatahi, Somaye

AU - Zhang, Y.

PY - 2019/8

Y1 - 2019/8

N2 - BackgroundFasting and energy restricting diets have a potential means of delaying or preventing the onset of a range of age-related metabolic and neoplastic diseases. Consistently at the centre of this effect appears to be a significant reduction in circulating IGF-1 levels. The aim of the current systematic review and meta-analysis was to determine the influence of fasting and energy restriction on IGF-1 levels in human subjects.MethodsA comprehensive systematic search was conducted from onset of the database to February 2019 in Embase, MEDLINE/PubMed, and SCOPUS to identify randomized clinical trials that investigating the impact of fasting or energy restriction circulating IGF-1 levels. Effect size was reported as weighted mean difference (WMD) and 95% confidence intervals (CI) using a random-effects models. Subgroup analysis was performed to identify the probable source of heterogeneity among trials.ResultsTotal pooling of fasting and energy restriction randomised controlled trials in WMD analysis revealed no significant effect on circulating IGF-1 levels (WMD: -16.41 ng/ml, 95% CI: -35.88, 3.07). Sub grouped analysis fasting regimens appeared to substantially reduce IGF-1 (WMD: -28.87 ng/ml, 95% CI: -43.69, -14.05, I2=00%), energy restricting regimens failed to do the same (WMD: -10.98 ng/ml, 95% CI: -33.08, 11.11, I2=90%). Within this final subgrouping, it was observed that only energy restriction regimens of 50% or greater of normal daily energy intake were capable of significantly reducing IGF-1 levels (WMD: -36.57 ng/ml, 95% CI: -59.19, -13.95, I2=00%). Finally, a meta regression were noted in which the percentage restriction of daily energy intake inversely correlated with plasma IGF-1 levels (p=0.04). ConclusionThis study uncovered that fasting significantly reduced levels of IGF-1, while energy restriction diets were successful only when intake was reduced by 50% or more.

AB - BackgroundFasting and energy restricting diets have a potential means of delaying or preventing the onset of a range of age-related metabolic and neoplastic diseases. Consistently at the centre of this effect appears to be a significant reduction in circulating IGF-1 levels. The aim of the current systematic review and meta-analysis was to determine the influence of fasting and energy restriction on IGF-1 levels in human subjects.MethodsA comprehensive systematic search was conducted from onset of the database to February 2019 in Embase, MEDLINE/PubMed, and SCOPUS to identify randomized clinical trials that investigating the impact of fasting or energy restriction circulating IGF-1 levels. Effect size was reported as weighted mean difference (WMD) and 95% confidence intervals (CI) using a random-effects models. Subgroup analysis was performed to identify the probable source of heterogeneity among trials.ResultsTotal pooling of fasting and energy restriction randomised controlled trials in WMD analysis revealed no significant effect on circulating IGF-1 levels (WMD: -16.41 ng/ml, 95% CI: -35.88, 3.07). Sub grouped analysis fasting regimens appeared to substantially reduce IGF-1 (WMD: -28.87 ng/ml, 95% CI: -43.69, -14.05, I2=00%), energy restricting regimens failed to do the same (WMD: -10.98 ng/ml, 95% CI: -33.08, 11.11, I2=90%). Within this final subgrouping, it was observed that only energy restriction regimens of 50% or greater of normal daily energy intake were capable of significantly reducing IGF-1 levels (WMD: -36.57 ng/ml, 95% CI: -59.19, -13.95, I2=00%). Finally, a meta regression were noted in which the percentage restriction of daily energy intake inversely correlated with plasma IGF-1 levels (p=0.04). ConclusionThis study uncovered that fasting significantly reduced levels of IGF-1, while energy restriction diets were successful only when intake was reduced by 50% or more.

KW - Energy restriction

KW - Fasting

KW - IGF-1

UR - http://www.scopus.com/inward/record.url?scp=85065886596&partnerID=8YFLogxK

U2 - 10.1016/j.arr.2019.100910

DO - 10.1016/j.arr.2019.100910

M3 - Article

VL - 53

JO - Ageing Research Reviews

JF - Ageing Research Reviews

SN - 1568-1637

M1 - 100910

ER -